drugset / Trial / NCT02786082

Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers

NCT02786082

Phase 1 Completed 29 enrolled Lee's Pharmaceutical Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective is to study the pharmacokinetics of Azilsartan Tablets in human and providing evidence for clinical study and clinical application of this product.

Timeline

Start
2016-11-01
Primary completion
2017-08-31
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Azilsartan Unknown 20 mg Oral
Subject Azilsartan Unknown 40 mg Oral

Indications